These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18820)

  • 21. Bone-marrow transplantation after antilymphocytic serum and lethal chemotherapy.
    Floersheim GL; Ruszkiewicz M
    Nature; 1969 May; 222(5196):854-7. PubMed ID: 4890346
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of immune reactions by antilymphocyte serum.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1978 Mar; 10(1):23-9. PubMed ID: 24907
    [No Abstract]   [Full Text] [Related]  

  • 23. Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients.
    Vallera DA; Soderling CC; Carlson GJ; Kersey JH
    Transplantation; 1982 Mar; 33(3):243-8. PubMed ID: 6121405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
    Gassmann W; Uharek L; Erbersdobler A; Glass B; Wottge HU; Schmitz N; Löffler H; Mueller-Ruchholtz W
    Br J Haematol; 1991 Jul; 78(3):310-8. PubMed ID: 1908309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
    Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
    Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E
    Exp Hematol; 1977 May; 5(3):215-35. PubMed ID: 326573
    [No Abstract]   [Full Text] [Related]  

  • 27. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 29. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

  • 30. Human marrow transplantation--current status.
    Buckner CD; Clift RA; Fefer A; Neiman P; Storb R; Thomas ED
    Prog Hematol; 1973; 8():299-324. PubMed ID: 4150971
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG).
    Kolb HJ; Bodenberger U; Rodt HV; Rieder I; Netzel B; Grosse-Wilde H; Scholz S; Thierfelder S
    Haematol Blood Transfus; 1980; 25():61-71. PubMed ID: 7021361
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

  • 34. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
    Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
    Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemopoietic grafts between DLA-identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum.
    Storb R; Weiden PL; Graham TC; Lerner KG; Nelson N; Thomas ED
    Transplantation; 1977 Nov; 24(5):349-57. PubMed ID: 21477
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival of rat bone marrow cells after treatment with myleran and endoxan.
    Dunjic A; Cuvelier AM
    Exp Hematol; 1973; 1(1):11-21. PubMed ID: 4608438
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of graft versus host reactions and conditioning of recipients for bone marrow transplantation in chickens.
    Ivanyi J
    Haematol Blood Transfus; 1980; 25():219-37. PubMed ID: 7021341
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression for clinical marrow transplantation.
    Santos GW
    Semin Hematol; 1974 Jul; 11(3):341-51. PubMed ID: 4151847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.